517 related articles for article (PubMed ID: 27655416)
1. The Synthetic Cannabinoids Phenomenon.
Karila L; Benyamina A; Blecha L; Cottencin O; Billieux J
Curr Pharm Des; 2016; 22(42):6420-6425. PubMed ID: 27655416
[TBL] [Abstract][Full Text] [Related]
2. Spice/K2 drugs--more than innocent substitutes for marijuana.
Zawilska JB; Wojcieszak J
Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
[TBL] [Abstract][Full Text] [Related]
3. Spicing things up: synthetic cannabinoids.
Spaderna M; Addy PH; D'Souza DC
Psychopharmacology (Berl); 2013 Aug; 228(4):525-40. PubMed ID: 23836028
[TBL] [Abstract][Full Text] [Related]
4. [Effect and occurrence of synthetic cannabinoids].
Tuv SS; Strand MC; Karinen R; Øiestad EL; Christophersen AS; Vindenes V
Tidsskr Nor Laegeforen; 2012 Oct; 132(20):2285-8. PubMed ID: 23736196
[TBL] [Abstract][Full Text] [Related]
5. [Synthetic cannabinoids--the new "legal high" drugs].
Berkovitz R; Arieli M; Marom E
Harefuah; 2011 Dec; 150(12):884-7, 937. PubMed ID: 22352277
[TBL] [Abstract][Full Text] [Related]
6. Psyclones: a roller coaster of life? Hidden synthetic cannabinoids and stimulants in apparently harmless products.
Santacroce R; Corazza O; Martinotti G; Bersani FS; Valeriani G; Di Giannantonio M
Hum Psychopharmacol; 2015 Jul; 30(4):265-71. PubMed ID: 26216561
[TBL] [Abstract][Full Text] [Related]
7. Spice drugs as a new trend: mode of action, identification and legislation.
Vardakou I; Pistos C; Spiliopoulou Ch
Toxicol Lett; 2010 Sep; 197(3):157-62. PubMed ID: 20566335
[TBL] [Abstract][Full Text] [Related]
8. The effects and risks associated to mephedrone and methylone in humans: A review of the preliminary evidences.
Karila L; Billieux J; Benyamina A; Lançon C; Cottencin O
Brain Res Bull; 2016 Sep; 126(Pt 1):61-67. PubMed ID: 26995278
[TBL] [Abstract][Full Text] [Related]
9. [Synthetic cannabinoids: spread, addiction biology & current perspective of personal health hazard].
Bonnet U; Mahler H
Fortschr Neurol Psychiatr; 2015 Apr; 83(4):221-31. PubMed ID: 25893495
[TBL] [Abstract][Full Text] [Related]
10. Synthetic cannabinoid receptor agonists: classification and nomenclature.
Potts AJ; Cano C; Thomas SHL; Hill SL
Clin Toxicol (Phila); 2020 Feb; 58(2):82-98. PubMed ID: 31524007
[No Abstract] [Full Text] [Related]
11. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.
Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F
Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533
[TBL] [Abstract][Full Text] [Related]
12. The synthetic cannabinoids phenomenon: from structure to toxicological properties. A review.
Alves VL; Gonçalves JL; Aguiar J; Teixeira HM; Câmara JS
Crit Rev Toxicol; 2020 May; 50(5):359-382. PubMed ID: 32530350
[TBL] [Abstract][Full Text] [Related]
13. Synthetic cannabinoid intoxication: a case series and review.
Harris CR; Brown A
J Emerg Med; 2013 Feb; 44(2):360-6. PubMed ID: 22989695
[TBL] [Abstract][Full Text] [Related]
14. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
[TBL] [Abstract][Full Text] [Related]
15. Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.
Castaneto MS; Gorelick DA; Desrosiers NA; Hartman RL; Pirard S; Huestis MA
Drug Alcohol Depend; 2014 Nov; 144():12-41. PubMed ID: 25220897
[TBL] [Abstract][Full Text] [Related]
16. Marijuana-based drugs: innovative therapeutics or designer drugs of abuse?
Seely KA; Prather PL; James LP; Moran JH
Mol Interv; 2011 Feb; 11(1):36-51. PubMed ID: 21441120
[TBL] [Abstract][Full Text] [Related]
17. [Spice drugs: cannabinoids as a new designer drugs].
Mustata C; Torrens M; Pardo R; Pérez C; ; Farré M
Adicciones; 2009; 21(3):181-6. PubMed ID: 19718488
[TBL] [Abstract][Full Text] [Related]
18. Synthetic cannabinoids: the dangers of spicing it up.
Salani DA; Zdanowicz MM
J Psychosoc Nurs Ment Health Serv; 2015 May; 53(5):36-43. PubMed ID: 25974923
[TBL] [Abstract][Full Text] [Related]
19. The Pharmacologic and Clinical Effects of Illicit Synthetic Cannabinoids.
White CM
J Clin Pharmacol; 2017 Mar; 57(3):297-304. PubMed ID: 27610597
[TBL] [Abstract][Full Text] [Related]
20. [Spice in France: mixed herbs containing synthetic cannabinoids].
Schlatter J; Chiadmi F; Chariot P
Ann Biol Clin (Paris); 2012; 70(4):413-22. PubMed ID: 22796613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
